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cells and progenitor cells exhibiting vasculogenesis had died.
These endothelial cells were then transduced with the gene for
prourokinase and seeded onto expanded polytetrafluoroethylene
graft material followed by testing for adherence as described in
the article. Thus, we were able to obtain sufficient cells, not only
for seeding, but transduction before seeding.
Cells that were exposed to magnetic beads in the process of
isolation were not suitable for cell expansion because they phago-
cytosed some of the magnetic beads, so proliferation was too slow.
We also found that too few cells were isolated by the magnetic-
bead method to make this a feasible method for seeding grafts.
Upon checking our original data, we discovered that we iso-
lated 1.52 ± 0.43  106 mononuclear cells per mL of peripheral
blood, which is comparable to what Dr Tiwari and colleagues
obtained. On page 185 we reported that tenfold fewer cells were
isolated, a computational mistake. In a separate publication1 we
reported approximately the same values as Dr Tiwari and col-
leagues. In this same publication, we further describe isolation
and proliferation of cells from adult peripheral blood. In addition,
we have completed studies with a series of dogs having carotid
artery grafts seeded with jugular vein endothelial cells on one side
and peripheral blood stem cell derived endothelial cells on the
other side, harvested at 1- and 6-month intervals, which show no
difference in patency whether seeded with jugular vein endothe-
lial cells or peripheral blood stem cell derived endothelial cells.2,3
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Regarding “Bedside vena cava filter placement guided
with intravascular ultrasound”
We wish to commend the authors for their work in develop-
ment of intravascular ultrasound (IVUS) guided delivery of infe-
rior vena cava (IVC) filters at the patient’s bedside (J Vasc Surg
2001;34:21-6). In the intensive care setting, a small proportion of
patients cannot be transported safely to the interventional radiol-
ogy suite for conventional fluoroscopically guided IVC filter place-
ment. At our institution, this usually involves patients with closed
head injuries and elevated intracranial pressure that compromises
cerebral perfusion when the patient is placed supine. For the read-
ership without access to or experience with IVUS but who have
portable fluoroscopy and cooperative interventional radiologists,
we would like to point out a technique for bedside placement of
IVC filters developed at the University of California, San Diego.1
Transcutaneous duplex ultrasound scanning is used to assess the
internal jugular and common femoral veins bilaterally to plan
venous access and the IVC to obtain diameter measurements for
specific filter selection. Portable fluoroscopy with digital subtrac-
tion angiographic capability is used to perform transcatheter con-
trast inferior vena cavography and bilateral renal venography to
confirm IVC diameter measurements and to evaluate for possible
renal vein and IVC anatomic variants that would alter filter place-
ment. Real-time fluoroscopy is used to guide device manipulation
and assess adequacy of filter placement after deployment.
We do not believe that bedside IVC filter placement is appro-
priate in patients without strong contraindications to transport to
the interventional radiology suite. The financial arguments based
on differential hospital charges for bedside IVC filter placement
are irrelevant given our current reimbursement environment.
Tradeoffs for bedside IVC filter placement can be considerable. In
the case of bedside IVC filter placement, breaches in the sterile
field are more likely (eg, a guidewire touching objects outside the
improvised sterile field), inventory is limited if difficulty is
encountered or items are dropped, the gold standard technique
of contrast venography is not used for identifying IVC and renal
vein variant anatomy that may alter the placement of the filter is
not used,2 and there is no mechanism for identifying, much less
correcting, maldeployed filters (eg, excessive tilt, asymmetric leg
deployment, or overlapping filter struts).3,4
In summary, we believe that bedside IVC filter placement is
a valuable alternative for these few patients with prohibitive risks
for transport, but it is a suboptimal technique for most patients.
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We would like to thank Drs Rose, Kinney, and Valji for their
comments, and we generally concur with their views, although
some points should be clarified.
Specific indications for this technique continue to undergo
refinement since this feasibility study. All patients in the research
study have contraindications to transport, such as an unstable
spine, continuous hemofiltration, hemodynamic instability, or
hypothermia. Patients who are not in intensive care were
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excluded, and the majority of caval filters are still performed in
the angiography suite or operating room. However, since begin-
ning this program, we have found that the clinicians at our insti-
tution enjoy having this option available for selected patients at
risk for transportation complications.
We agree that comprehensive cost analysis is useful to assess
comparable techniques. The charge analysis showed no significant
difference, and a subsequent cost analysis of a second cohort demon-
strates that the bedside IVUS technique is less expensive. Neither of
these analyses account for lost opportunity for income in the operat-
ing room or angiography suite, which is likely to be significant.
The research protocol was designed with patient safety as a
primary concern, and aseptic techniques approved by the infec-
tion control director of our hospital were used. The thyroid drape
provides length to cover the foot of the bed and side rails, mini-
mizing the risk of contamination. No infections were experienced
in this series. Staff are familiar with aseptic techniques in the
intensive care unit because right heart catheterization, tra-
cheostomy, gastrostomy, abdominal packing changes, and other
more invasive operations are commonly performed when the rel-
ative risks of transportation outweigh bedside risks. Also, the
mobile cart includes backup inventory, and no procedure was
aborted because of catheter malfunction, contamination, or
unavailable supplies. It is important to emphasize planning before
undertaking these procedures.
Intravascular ultrasound scanning may detect some vena cava
abnormalities better than conventional imaging.1 If the anatomy
cannot be clearly defined with IVUS, we would opt for conven-
tional filter placement using fluoroscopy.
We are familiar with the innovative work of Hicks et al with
routine selective renal venography. However, this is not a stand-
ard practice in the placement of caval filters at our institution
because we are not aware of any demonstration of clinical efficacy
with these different techniques. Lastly, postprocedure radi-
ographs were performed in this study to assess positioning, and if
there is a patient with a maldeployed filter, we would recommend
corrective action under fluoroscopic guidance.
In summary, bedside vena cava filter placement is a useful
option for selected patients, although careful planning and famil-
iarity with the technique are important.
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Regarding “High endogenous estradiol is associated
with increased venous distensibility and clinical
evidence of varicose veins in menopausal women”
We read the article of Ciardullo et al (J Vasc Surg
2001;32:544-9) with great interest, and even more so the com-
ments by Georgiev.1 We agree with Georgiev in that just by meas-
uring estrogen levels, venous capacity, and the rate of varicose
veins, one cannot reach conclusions that “high serum levels of
estrogen induced increased venous distensibility” and that the
connection of this relationship to the incidence of varicose veins
cannot be firmly established based on Ciardullo’s findings. Since
Gregoriev’s letter, it has been shown with appropriate method
that female sex hormones increase venous distensibility.2-3 Since
the above studies also report that venous distensibility decreases
in animal models of menopause, and Ciardullo did not use a con-
trol group with normal cycle, we feel that any speculations for a
direct relationship between increased distensibility and an increase
in venous varicosity should be considered very cautiously.
Moreover, it can further confuse the interpretation of their results
on varicose veins and estrogen level in postmenopausal women
that they did not report the duration of varicose veins. It would
obviously make a big difference whether the menopausal patients
developed varicose veins 1 to 2 years before the study or 20 to 
30 years ago, as many women have varicose veins as early as their
first pregnancy.
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The title of our paper defines very sharply our point of
view—we affirm that high endogenous estradiol is associated with
increased venous distensibility and clinical evidence of varicose
veins in menopausal women. To evaluate this association, we ana-
lyzed the cross-sectional data of the screenees for a trial on diet
and hormones.1 By indication our design is not conclusive to
demonstrate a causal relationship. We have compared groups of
menopausal women with different venous distensibility and
prevalence of varicose veins and have evaluated their endogenous
statements on causality; according to our findings, it is likely that
the residual estradiol level in menopausal women may play a role,
a starting point for new and specifically structured studies in
women.
We acknowledge the importance of the articles cited by Dr
Szaky. These studies have been carried out in ovariectomized rats
(not in women) and deal with hormone replacement and not with
endogenous hormones; in general, they point out results that we
should expect on the basis of our knowledge on the effect of
estrogen replacement on the venous system.
Dr Szaky’s observation that the absence of a comparison
group of women with normal cycle is the reason to be cautious
has no ground since there he presumes a comparison between
menopausal and premenopausal women, which certainly can
complicate rather than indicate the path to a causal relationship
evaluation.
